Serologic associations of anti-cytoplasmic antibodies identified during anti-nuclear antibody testing

Clinical Chemistry and Laboratory Medicine

Volumn 44, Issue 10, 2006, Pages 1283-1286

  Craig, Wendy Y ^a   Ledue, Thomas B ^a   Collins, Marilyn F ^a   Meggison, William E ^a   Leavitt, Lynda F ^a   Ritchie, Robert F ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

Anti cytoplasmic antibody; Anti nuclear antibody; Extractable nuclear antigen; Indirect immunofluorescence assay

Indexed keywords

ANTICYTOPLASMIC ANTIBODY; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CELL NUCLEUS ANTIGEN; GRANULOCYTE ANTIBODY; HISTONE; HISTONE ANTIBODY; JO 1 ANTIBODY; LA ANTIBODY; MICROSOME ANTIBODY; MITOCHONDRION ANTIBODY; PARIETAL CELL ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; LABORATORY TEST; PRIORITY JOURNAL; SERODIAGNOSIS; STAINING;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; SEROLOGIC TESTS;

EID: 33750092259     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2006.232     Document Type: Article

References (19)

1. Solomon DH, Kavanaugh AJ, Schur PH, and the American College of Rheumatology and Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47:434-44.
2. Von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic disease. Seminars Arthritis Rheum 1995;24:323-58.
3. Kavanaugh A, Tomar R, Reveille J, Solomon D, Homberger H. Guidelines for clinical use of the antinuclear antibody test for specific autoantibodies to nuclear antigens. Arch Pathol Lab Med 2000;124:71-81.
4. Peene I, Meheus L, Veys EM, De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60:1131-6.
5. Bossuyt X, Hendrickx A, Frans J. Antinuclear antibody titer and antibodies to extractable nuclear antigens. Arthritis Rheum 2005;53:987-8.
6. Hoffman IE, Peene I, Veys EM, de Keyser F. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem 2002;48:2171-6.
7. Bossuyt X, Luyckx A. Antibodies to extractable nuclear antigens in antinuclear antibody-negative samples. Clin Chem 2005;51:2426-7.
8. Koh W-H, Dunphy J, Whyte J, Dixey J, McHugh NJ. Characterization of anti-cytoplasmic antibodies and their clinical associations. Ann Rheum Dis 1995;54:269-73.
9. Keech CL, Gordon TP, McCluskey J. Cytoplasmic accumulation of the 52 kDa/SS-A nuclear autoantigen in transfected cell lines. J Autoimmunity 1995;8:699-712.
10. Shi MH, Tsui FW, Rubin LA. Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts. J Rheumatol 1991;18:252-8.
11. Hardin JA, Rahn DR, Shen C, Lerner MR, Wolin SL, Rosa MD, et al. Antibodies from patients with connective tissue diseases bind specific subsets of cellular RNA-protein particles. J Clin Invest 1982;70:141-7.
12. Reichlin M, Arnett FC. Multiplicity of antibodies in myositis sera. Arthritis Rheum 1984;27:1150-6.
13. Lems WF, van Schaardenburg D, van de Stadt RJ. Cytoplasmic staining, ANA negative status and ENA testing in rheumatic diseases. Ann Rheum Dis 1995;54:779.
14. Craig WY, Ledue TB, Johnson AM, Ritchie RF. The distribution of anti-nuclear antibodies in "normal" children and adults. J Rheumatol 1999;26:914-9.
15. Ritchie RF, Collins M, Ledue TB. A flexible, efficient, checkerboard immunoblot system for the detection and semiquantitation of specific antinuclear antibodies. J Clin Lab Anal 1992;6:391-8.
16. Radice A, Sinico RA. Antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 2005;38:93-103.
17. Sihvonen S, Korpela M, Mustila A, Mustonen J. The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinuted peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis. J Rheumatol 2005;32:2089-94.
18. Sinclair D. Clinical and laboratory aspects of thyroid autoantibodies. Ann Clin Biochem 2006;43:173-83.
19. Berg PA, Klein R. Antimitochondrial antibodies in primary biliary cirrhosis and other disorders: definition and clinical relevance. Dig Dis 1992;10:85-101.